Interplay between malic enzyme 2, de novo serine synthesis, and the malate-aspartate shuttle drives metabolic adaptation in triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: Interplay between malic enzyme 2, de novo serine synthesis, and the malate-aspartate shuttle drives metabolic adaptation in triple-negative breast cancer.
Authors: Jeon JH; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States.; Department of Biomedical Engineering, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Laboratory for Systems Biology of Human Diseases, University of Michigan, MI, 48109, Ann Arbor, United States.; Biointerfaces Institute, University of Michigan, MI, 48109, Ann Arbor, United States., Slayton MD; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States., Krinkel B; School of Biological Sciences, University of Auckland, Auckland, New Zealand., Animasahun O; Department of Biomedical Engineering, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA., Shankaran A; Department of Biomedical Engineering, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA., Wuchu F; Department of Biomedical Engineering, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA., Nenwani M; Department of Biomedical Engineering, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA., Farah Z; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States., Burke J; School of Biological Sciences, University of Auckland, Auckland, New Zealand., Achreja A; Department of Biomedical Engineering, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA., Nilaj B; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States., Kohagen K; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States., Eu YH; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States., Rosenfeld A; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States., Collard M; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States., Bao L; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States., Cheng X; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States., Kleer C; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States., Squire C; School of Biological Sciences, University of Auckland, Auckland, New Zealand., Loomes K; School of Biological Sciences, University of Auckland, Auckland, New Zealand., Nagrath D; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States. dnagrath@umich.edu.; Department of Biomedical Engineering, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA. dnagrath@umich.edu.; Department of Chemical Engineering, University of Michigan, MI, 48109, Ann Arbor, United States. dnagrath@umich.edu.; Laboratory for Systems Biology of Human Diseases, University of Michigan, MI, 48109, Ann Arbor, United States. dnagrath@umich.edu.; Biointerfaces Institute, University of Michigan, MI, 48109, Ann Arbor, United States. dnagrath@umich.edu., Merajver SD; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA. smerajve@med.umich.edu.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States. smerajve@med.umich.edu.
Source: Cancer & metabolism [Cancer Metab] 2025 Oct 14; Vol. 13 (1), pp. 42. Date of Electronic Publication: 2025 Oct 14.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101607582 Publication Model: Electronic Cited Medium: Print ISSN: 2049-3002 (Print) Linking ISSN: 20493002 NLM ISO Abbreviation: Cancer Metab Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41088330
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Interplay between malic enzyme 2, de novo serine synthesis, and the malate-aspartate shuttle drives metabolic adaptation in triple-negative breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jeon+JH%22">Jeon JH</searchLink>; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States.; Department of Biomedical Engineering, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Laboratory for Systems Biology of Human Diseases, University of Michigan, MI, 48109, Ann Arbor, United States.; Biointerfaces Institute, University of Michigan, MI, 48109, Ann Arbor, United States.<br /><searchLink fieldCode="AU" term="%22Slayton+MD%22">Slayton MD</searchLink>; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States.<br /><searchLink fieldCode="AU" term="%22Krinkel+B%22">Krinkel B</searchLink>; School of Biological Sciences, University of Auckland, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Animasahun+O%22">Animasahun O</searchLink>; Department of Biomedical Engineering, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.<br /><searchLink fieldCode="AU" term="%22Shankaran+A%22">Shankaran A</searchLink>; Department of Biomedical Engineering, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.<br /><searchLink fieldCode="AU" term="%22Wuchu+F%22">Wuchu F</searchLink>; Department of Biomedical Engineering, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.<br /><searchLink fieldCode="AU" term="%22Nenwani+M%22">Nenwani M</searchLink>; Department of Biomedical Engineering, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.<br /><searchLink fieldCode="AU" term="%22Farah+Z%22">Farah Z</searchLink>; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States.<br /><searchLink fieldCode="AU" term="%22Burke+J%22">Burke J</searchLink>; School of Biological Sciences, University of Auckland, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Achreja+A%22">Achreja A</searchLink>; Department of Biomedical Engineering, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.<br /><searchLink fieldCode="AU" term="%22Nilaj+B%22">Nilaj B</searchLink>; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States.<br /><searchLink fieldCode="AU" term="%22Kohagen+K%22">Kohagen K</searchLink>; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States.<br /><searchLink fieldCode="AU" term="%22Eu+YH%22">Eu YH</searchLink>; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States.<br /><searchLink fieldCode="AU" term="%22Rosenfeld+A%22">Rosenfeld A</searchLink>; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States.<br /><searchLink fieldCode="AU" term="%22Collard+M%22">Collard M</searchLink>; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States.<br /><searchLink fieldCode="AU" term="%22Bao+L%22">Bao L</searchLink>; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States.<br /><searchLink fieldCode="AU" term="%22Cheng+X%22">Cheng X</searchLink>; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States.<br /><searchLink fieldCode="AU" term="%22Kleer+C%22">Kleer C</searchLink>; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States.<br /><searchLink fieldCode="AU" term="%22Squire+C%22">Squire C</searchLink>; School of Biological Sciences, University of Auckland, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Loomes+K%22">Loomes K</searchLink>; School of Biological Sciences, University of Auckland, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Nagrath+D%22">Nagrath D</searchLink>; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States. dnagrath@umich.edu.; Department of Biomedical Engineering, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA. dnagrath@umich.edu.; Department of Chemical Engineering, University of Michigan, MI, 48109, Ann Arbor, United States. dnagrath@umich.edu.; Laboratory for Systems Biology of Human Diseases, University of Michigan, MI, 48109, Ann Arbor, United States. dnagrath@umich.edu.; Biointerfaces Institute, University of Michigan, MI, 48109, Ann Arbor, United States. dnagrath@umich.edu.<br /><searchLink fieldCode="AU" term="%22Merajver+SD%22">Merajver SD</searchLink>; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 48109, USA. smerajve@med.umich.edu.; Rogel Cancer Center, Michigan Medicine, University of Michigan, MI, 48109, Ann Arbor, United States. smerajve@med.umich.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101607582%22">Cancer & metabolism</searchLink> [Cancer Metab] 2025 Oct 14; Vol. 13 (1), pp. 42. <i>Date of Electronic Publication: </i>2025 Oct 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101607582 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2049-3002 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220493002%22">20493002 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Metab <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41088330
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s40170-025-00410-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 42
    Titles:
      – TitleFull: Interplay between malic enzyme 2, de novo serine synthesis, and the malate-aspartate shuttle drives metabolic adaptation in triple-negative breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jeon JH
      – PersonEntity:
          Name:
            NameFull: Slayton MD
      – PersonEntity:
          Name:
            NameFull: Krinkel B
      – PersonEntity:
          Name:
            NameFull: Animasahun O
      – PersonEntity:
          Name:
            NameFull: Shankaran A
      – PersonEntity:
          Name:
            NameFull: Wuchu F
      – PersonEntity:
          Name:
            NameFull: Nenwani M
      – PersonEntity:
          Name:
            NameFull: Farah Z
      – PersonEntity:
          Name:
            NameFull: Burke J
      – PersonEntity:
          Name:
            NameFull: Achreja A
      – PersonEntity:
          Name:
            NameFull: Nilaj B
      – PersonEntity:
          Name:
            NameFull: Kohagen K
      – PersonEntity:
          Name:
            NameFull: Eu YH
      – PersonEntity:
          Name:
            NameFull: Rosenfeld A
      – PersonEntity:
          Name:
            NameFull: Collard M
      – PersonEntity:
          Name:
            NameFull: Bao L
      – PersonEntity:
          Name:
            NameFull: Cheng X
      – PersonEntity:
          Name:
            NameFull: Kleer C
      – PersonEntity:
          Name:
            NameFull: Squire C
      – PersonEntity:
          Name:
            NameFull: Loomes K
      – PersonEntity:
          Name:
            NameFull: Nagrath D
      – PersonEntity:
          Name:
            NameFull: Merajver SD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 10
              Text: 2025 Oct 14
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2049-3002
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer & metabolism
              Type: main
ResultId 1